Last update :
18/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Anti-arrhythmic   Amiodarone hydrochloride  
Injection
Capsule Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Acrodarona Ecuador
Amidovin Turkey
Amiocar Argentina, Peru
Amiodar Italy
Amiodaron Germany, Norway, Sweden
Amiodarona Argentina, Chile, Colombia, Ecuador, Mexico, Peru
Amiodarone Australia, Canada, Great Britain, Iran, Italy, Luxembourg, New Zealand, United States of America
Amiohexal Germany
Amiokordin Hungary, Poland, Romania
Amiorit Venezuela
Ancoron Brazil
Angoron Greece
Asulblan Argentina
Atlansil Argentina, Brazil, Chile, Ecuador, Peru
Cardasol India
Cardichek India
Cardio Egypt
Cirtrent Mexico
Cordalin Turkey
Cordarex Germany
Cordarone Australia, Belgium, Chile, Colombia, Denmark, Ecuador, Finland, France, Great Britain, Hungary, Iceland, Ireland, Italy, Luxembourg, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Saudi Arabia, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, United States of America
Duron India
Eudarona Venezuela
Eurythmic India
Farcodarone Egypt
Ronecard Egypt
Sedacoron Austria, Poland, Romania, Saudi Arabia, Tunisia
Sedacorone Iran
Trangorex Spain, Venezuela
Stability in solutions   Injection   Stability in solutions : Amiodarone hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Protect from light
32 Day
647
Level of evidence A
Glass NaCl 0,9% or Glucose 5% 2 mg/ml 5°C Protect from light
32 Day
647
Level of evidence A
Glass Sodium chloride 0,9% 0,84 mg/ml 25°C Light
6 Hour
1733
Level of evidence B
Glass Glucose 5% 0,6 mg/ml 22°C-24°C Not specified
5 Day
379

Polyolefine NaCl 0,9% or Glucose 5% 1,8 mg/ml 24°C Light
24 Hour
242
Level of evidence C
Polyolefine Glucose 5% 0,9 mg/ml 25°C Light
24 Hour
2146
Level of evidence B
Polypropylen Syringe Glucose 5% 25 mg/ml 2-8°C Protect from light
28 Day
4252
Level of evidence B+
  Mentions Légales